Yixuan Tang

机构：China Pharmaceutical University, Harbin Institute of Technology, State Key Laboratory of Natural Medicine · ORCID：0000-0003-2755-8269

发表论文 19 篇 · 总被引 601 次 · h-index 7

代表论文

• Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a “Don’t-Eat-Us” Strategy (2019 · ACS Nano · 被引 339)
• Nanoparticles Targeted against Cryptococcal Pneumonia by Interactions between Chitosan and Its Peptide Ligand (2018 · Nano Letters · 被引 83)
• Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia (2017 · Nature Communications · 被引 68)
• Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management (2023 · International Journal of Nanomedicine · 被引 40)
• Engineered liposomes targeting the gut–CNS Axis for comprehensive therapy of spinal cord injury (2021 · Journal of Controlled Release · 被引 26)
• Advances in constructing biocompatible nanocarriers (2025 · Drug Delivery and Translational Research · 被引 11)